Skip to Main Content

Paper Details

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia.
Intensive Care Med
12
2022
COVID-19, EQ, EQ-5D, coronavirus disease 2019, dexamethasone, hypoxaemia, oxygen, patients
Author NameAffiliation
Balasubramanian VenkateshThe George Institute for Global Health, University of New South Wales
Naomi HammondThe George Institute for Global Health, University of New South Wales
Naomi HammondRoyal North Shore Hospital
Pravin AminBombay Hospital Institute of Medical Sciences
Michelle S ChewBiomedical and Clinical Sciences, Linkoping University
  • 1 - 5

Datasets

Release 1.2